Prescription Digital Therapeutics

Latest News

GPT-4 Carries Risk of Re-Enforcing Bias, Stereotypes, Study Finds
GPT-4 Carries Risk of Re-Enforcing Bias, Stereotypes, Study Finds

January 22nd 2024

A research team led by University of California, San Francisco, found flaws in how the large language model assessed prevalence and made differential diagnoses.

Microgen-stock.adobe.com
Modeling Finds FDA-Authorized Diabetes Digital Therapeutic Can be Cost-Effective

January 18th 2024

Prescription Digital Therapeutic App for Schizophrenia Receives Breakthrough Device Designation From the FDA
Prescription Digital Therapeutic App for Schizophrenia Receives Breakthrough Device Designation From the FDA

January 16th 2024

FDA Expands Akili's EndeavorRx Game-Based Digital Therapy for ADHD Eligibility to Ages 8-17
FDA Expands Akili's EndeavorRx Game-Based Digital Therapy for ADHD Eligibility to Ages 8-17

December 21st 2023

Zivian Health Shares 2024 Healthcare Trends Predictions: Embracing Tech to Address Staffing Shortages, Patient Care
Zivian Health Shares 2024 Healthcare Trends Predictions: Embracing Tech to Address Staffing Shortages, Patient Care

December 8th 2023

More News

© 2024 MJH Life Sciences

All rights reserved.